b

bluebird bio

550 employees

Bluebird Bio is a biopharma company that develops and commercializes gene therapies for the treatment of severe genetic diseases and cancer.

Investor insights

Sectors invested in

Therapeutics1

Cancer Immonotherapy1

Clinical Grade Cell Therapy1

Biotechnology1

Health Care1

Stratified Medicine1

Regenerative Medicine1

Funding rounds participated in

$16M sweet spot round size

Most of their 1 investments are in rounds between $16M and $16M

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Health Diagnostics

Genetics

gene therapy

gene addition

Pharmaceutical

cerebral adrenoleukodystrophy

beta-thalassemia

sickle cell disease

Date founded

1993

Investments made

T

TC BioPharm Limited raised $16M on December 7, 2017

Investors: Renaissance Capital Partners and bluebird bio

Funding rounds raised

Total raised

$60M

from 15 investors over 15 rounds

b

bluebird bio raised $60M on July 25, 2012

Investors: TVM Life Science Management Inc, Deerfield Partners, RA Capital Management, L.P., Third Rock Ventures, Forbion and ARCH Venture Partners

b

bluebird bio raised $30M on April 20, 2011

Investors: TVM Life Science Management Inc, Forbion, ARCH Venture Partners, Easton Capital Investment Group and Third Rock Ventures

b

bluebird bio raised $12M on October 7, 2004

Investors: Techno Venture Management, Easton Capital Investment Group and ABN AMRO Energy Transition Fund

b

bluebird bio raised $8.5M on June 17, 2004

Investors: ABN AMRO Energy Transition Fund